The 93rd China International Medical Equipment Fair (CMEF)
From April 9 to 12, 2026, the 93rd China International Medical Equipment Fair (CMEF) concluded successfully at the National Exhibition and Convention Center (Shanghai). Under the theme “Innovation Convergence, Infinite Leap,” the event spanned a total area of over 320,000 square meters, bringing together nearly 5,000 branded companies from more than 30 countries and regions. It attracted over 300,000 professional visitors from more than 150 countries and regions, marking it as the flagship event of the global healthcare industry at the start of the 15th Five-Year Plan period.
Microcure made a strong appearance at the exhibition, showcasing its intelligent insufflation system and a series of innovative products for minimally invasive surgery. The company demonstrated its deep technological expertise and comprehensive solutions in the field of minimally invasive surgery, drawing high foot traffic and engaging discussions at its booth.
During the fair, the Microcure intelligent insufflation system, recognized for its exceptional stability and intelligent performance, was hailed by numerous surgical experts as a key trend driving the advancement of precision minimally invasive surgery. Meanwhile, the newly upgraded line of surgical consumables also received positive clinical feedback, with their reliability and innovative design offering new options for addressing real-world surgical challenges.
Throughout the event, Microcure Medical engaged in productive dialogues with medical institutions, seasoned distributors, and industry partners from multiple countries and regions, including South Korea, India, Russia, Germany, Brazil, Southeast Asia, and the Middle East, covering topics such as technology application, local needs, and collaboration models. The company also held in-depth discussions with leading domestic hospitals, medical groups, and partners. In numerous one-on-one meetings, both domestic and international clients highly commended the compliance, reliability, and clinical value of Microcure’s products, expressing strong interest in deepening regional cooperation.
Through this presence in Shanghai, Microcure Medical precisely connected with high-potential medical markets worldwide, engaging in in-depth exchanges with over 200 partners and reaching multiple cooperation agreements, adding new momentum to healthcare innovation and empowerment.
Microcure remains committed to compliance as its foundation and reliability as its core, providing trustworthy products to healthcare systems around the globe. We sincerely invite colleagues from all sectors to explore together the development trends in minimally invasive surgery and regional market opportunities. We look forward to collaborating with more global partners, leveraging continuous innovation and tangible clinical value to serve a broader patient population and jointly advance the progress and development of the minimally invasive surgery field.
Microcure is dedicated to the R&D and manufacturing of innovative devices for minimally invasive surgery. Its core product, the intelligent insufflation system, has been serving leading medical institutions both domestically and internationally, consistently safeguarding the safety of minimally invasive procedures.